Catalyst Event
Hangzhou Tigermed Consulting Co Ltd (3347) · Other
From Akros SCHK HK-Global Genomics Index (ASHGGENM)
5/13/2026, 12:00:00 AM
Announced a share repurchase plan for A-shares with a total amount of RMB 500 million to RMB 1 billion, at a price not exceeding RMB 60.00 per share, announced on May 13, 2026. The shares will be used for employee incentives or cancellation. This large-scale buyback is estimated to have a price impact of ≥5%.
Korean Translation
2026년 5월 13일, 총 5억~10억 위안 규모의 A주 자사주 매입 계획을 발표함. 매입 가격은 주당 60.00위안을 초과하지 않으며, 매입된 주식은 직원 인센티브 또는 소각에 사용될 예정임. 이는 5% 이상의 주가 상승을 견인할 것으로 예상됨.
Related Recent Events
JD Health International Inc (6618) · Earnings Release
Low importance estimated as no market reaction has occurred yet; Q2 2026 earnings report scheduled.
8/12/2026, 12:00:00 AM
Livzon Pharmaceutical Group Inc (1513) · Other
Ex-dividend date on June 16, 2026, for the final dividend of RMB 1.43 per 10 shares, scheduled to be paid on July 13, 2026. Low importance estimated as the dividend amount is within historical norms, scheduled.
6/16/2026, 12:00:00 AM
Grand Pharmaceutical Group Ltd (512) · Other
Ex-dividend date (2026-06-12) for the proposed 2025 final dividend of HK$0.169 per share is scheduled.
6/12/2026, 12:00:00 AM
Veracyte Inc (VCYT) · Other
Annual Meeting of Stockholders on 2026-06-10, with proposals including the election of directors and an expansion of the 2023 Equity Incentive Plan scheduled.
6/10/2026, 12:00:00 AM
Innovent Biologics Inc (1801) · Other
Innovent will present obesity pipeline data at the ADA Scientific Sessions on June 5-8, 2026; this low-impact event is scheduled
6/5/2026, 12:00:00 AM
Pacific Biosciences of California Inc (PACB) · Other
The 2026 Annual Meeting of Stockholders is scheduled for June 3, 2026, including a proposal to increase the number of shares reserved for the 2020 Equity Incentive Plan by 16,000,000. A low impact is estimated due to potential share dilution, scheduled.
6/3/2026, 12:00:00 AM